APO Research
Talk to an analyst

APO RESEARCH · REPORT

BCG Tuberculosis (TB) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global BCG Tuberculosis (TB) Vaccine Market Analysis and Forecast 2026-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchBCG Tuberculosis (TB) Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal BCG Tuberculosis (TB) Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal BCG Tuberculosis (TB) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal BCG Tuberculosis (TB) Vaccine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal BCG Tuberculosis (TB) Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global BCG Tuberculosis (TB) Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for BCG Tuberculosis (TB) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for BCG Tuberculosis (TB) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for BCG Tuberculosis (TB) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for BCG Tuberculosis (TB) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of BCG Tuberculosis (TB) Vaccine include China National Biotec, Sanofi Pasteur, Merck, Serum Institute of India, Japan BCG Lab, Intervax and GSBPL, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for BCG Tuberculosis (TB) Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of BCG Tuberculosis (TB) Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for BCG Tuberculosis (TB) Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the BCG Tuberculosis (TB) Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global BCG Tuberculosis (TB) Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for BCG Tuberculosis (TB) Vaccine sales, projected growth trends, production technology, application and end-user industry.

BCG Tuberculosis (TB) Vaccine Segment by Company

China National Biotec

Sanofi Pasteur

Merck

Serum Institute of India

Japan BCG Lab

Intervax

GSBPL

BCG Tuberculosis (TB) Vaccine Segment by Type

Immune BCG

Therapy BCG

BCG Tuberculosis (TB) Vaccine Segment by Application

Hospital

Clinic

BCG Tuberculosis (TB) Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCG Tuberculosis (TB) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of BCG Tuberculosis (TB) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCG Tuberculosis (TB) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of BCG Tuberculosis (TB) Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of BCG Tuberculosis (TB) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, BCG Tuberculosis (TB) Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global BCG Tuberculosis (TB) Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immune BCG Major Manufacturers Table 3. Therapy BCG Major Manufacturers Table 4. Global BCG Tuberculosis (TB) Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. BCG Tuberculosis (TB) Vaccine Industry Trends Table 8. BCG Tuberculosis (TB) Vaccine Industry Drivers Table 9. BCG Tuberculosis (TB) Vaccine Industry Opportunities and Challenges Table 10. BCG Tuberculosis (TB) Vaccine Industry Restraints Table 11. Global BCG Tuberculosis (TB) Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global BCG Tuberculosis (TB) Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global BCG Tuberculosis (TB) Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global BCG Tuberculosis (TB) Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global BCG Tuberculosis (TB) Vaccine Sales by Region (2021-2026) & (k units) Table 18. Global BCG Tuberculosis (TB) Vaccine Sales by Region (2027-2032) & (k units) Table 19. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2021-2026) Table 20. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2027-2032) Table 21. Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global BCG Tuberculosis (TB) Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global BCG Tuberculosis (TB) Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global BCG Tuberculosis (TB) Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global BCG Tuberculosis (TB) Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global BCG Tuberculosis (TB) Vaccine Manufacturers, Product Type & Application Table 29. Global BCG Tuberculosis (TB) Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global BCG Tuberculosis (TB) Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global BCG Tuberculosis (TB) Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global BCG Tuberculosis (TB) Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 39. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2027-2032) & (k units) Table 40. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2021-2026) Table 41. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2027-2032) Table 42. Global BCG Tuberculosis (TB) Vaccine Price by Type (2021-2026) & (US$/unit) Table 43. Global BCG Tuberculosis (TB) Vaccine Price by Type (2027-2032) & (US$/unit) Table 44. Global BCG Tuberculosis (TB) Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global BCG Tuberculosis (TB) Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 51. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2027-2032) & (k units) Table 52. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2021-2026) Table 53. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2027-2032) Table 54. Global BCG Tuberculosis (TB) Vaccine Price by Application (2021-2026) & (US$/unit) Table 55. Global BCG Tuberculosis (TB) Vaccine Price by Application (2027-2032) & (US$/unit) Table 56. China National Biotec Company Information Table 57. China National Biotec Business Overview Table 58. China National Biotec BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. China National Biotec BCG Tuberculosis (TB) Vaccine Product Portfolio Table 60. China National Biotec Recent Development Table 61. Sanofi Pasteur Company Information Table 62. Sanofi Pasteur Business Overview Table 63. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Portfolio Table 65. Sanofi Pasteur Recent Development Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Merck BCG Tuberculosis (TB) Vaccine Product Portfolio Table 70. Merck Recent Development Table 71. Serum Institute of India Company Information Table 72. Serum Institute of India Business Overview Table 73. Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Portfolio Table 75. Serum Institute of India Recent Development Table 76. Japan BCG Lab Company Information Table 77. Japan BCG Lab Business Overview Table 78. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Portfolio Table 80. Japan BCG Lab Recent Development Table 81. Intervax Company Information Table 82. Intervax Business Overview Table 83. Intervax BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Intervax BCG Tuberculosis (TB) Vaccine Product Portfolio Table 85. Intervax Recent Development Table 86. GSBPL Company Information Table 87. GSBPL Business Overview Table 88. GSBPL BCG Tuberculosis (TB) Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. GSBPL BCG Tuberculosis (TB) Vaccine Product Portfolio Table 90. GSBPL Recent Development Table 91. North America BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 92. North America BCG Tuberculosis (TB) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 93. North America BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 94. North America BCG Tuberculosis (TB) Vaccine Sales by Type (2027-2032) & (k units) Table 95. North America BCG Tuberculosis (TB) Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 96. North America BCG Tuberculosis (TB) Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 97. North America BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 98. North America BCG Tuberculosis (TB) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 99. North America BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 100. North America BCG Tuberculosis (TB) Vaccine Sales by Application (2027-2032) & (k units) Table 101. North America BCG Tuberculosis (TB) Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 102. North America BCG Tuberculosis (TB) Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 103. North America BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. North America BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. North America BCG Tuberculosis (TB) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 107. North America BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 108. North America BCG Tuberculosis (TB) Vaccine Sales by Country (2027-2032) & (k units) Table 109. North America BCG Tuberculosis (TB) Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 110. North America BCG Tuberculosis (TB) Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 111. United States BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 112. Canada BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 113. Mexico BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 114. Europe BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe BCG Tuberculosis (TB) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 117. Europe BCG Tuberculosis (TB) Vaccine Sales by Type (2027-2032) & (k units) Table 118. Europe BCG Tuberculosis (TB) Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 119. Europe BCG Tuberculosis (TB) Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 120. Europe BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe BCG Tuberculosis (TB) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 123. Europe BCG Tuberculosis (TB) Vaccine Sales by Application (2027-2032) & (k units) Table 124. Europe BCG Tuberculosis (TB) Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 125. Europe BCG Tuberculosis (TB) Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 126. Europe BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. Europe BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 130. Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 131. Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2027-2032) & (k units) Table 132. Europe BCG Tuberculosis (TB) Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 133. Europe BCG Tuberculosis (TB) Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 134. Germany BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 135. France BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 136. U.K. BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 137. Italy BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 138. Russia BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 139. Spain BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 140. Netherlands BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 141. Switzerland BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 142. Sweden BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 143. Poland BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 144. China BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 145. China BCG Tuberculosis (TB) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 146. China BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 147. China BCG Tuberculosis (TB) Vaccine Sales by Type (2027-2032) & (k units) Table 148. China BCG Tuberculosis (TB) Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 149. China BCG Tuberculosis (TB) Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 150. China BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 151. China BCG Tuberculosis (TB) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 152. China BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 153. China BCG Tuberculosis (TB) Vaccine Sales by Application (2027-2032) & (k units) Table 154. China BCG Tuberculosis (TB) Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 155. China BCG Tuberculosis (TB) Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 156. Asia BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia BCG Tuberculosis (TB) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 159. Asia BCG Tuberculosis (TB) Vaccine Sales by Type (2027-2032) & (k units) Table 160. Asia BCG Tuberculosis (TB) Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 161. Asia BCG Tuberculosis (TB) Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 162. Asia BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia BCG Tuberculosis (TB) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 165. Asia BCG Tuberculosis (TB) Vaccine Sales by Application (2027-2032) & (k units) Table 166. Asia BCG Tuberculosis (TB) Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 167. Asia BCG Tuberculosis (TB) Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 168. Asia BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia BCG Tuberculosis (TB) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 172. Asia BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 173. Asia BCG Tuberculosis (TB) Vaccine Sales by Country (2027-2032) & (k units) Table 174. Asia BCG Tuberculosis (TB) Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 175. Asia BCG Tuberculosis (TB) Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 176. Japan BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 177. South Korea BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 178. India BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 179. Australia BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 180. Taiwan BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 182. SAMEA BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA BCG Tuberculosis (TB) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2026) & (k units) Table 185. SAMEA BCG Tuberculosis (TB) Vaccine Sales by Type (2027-2032) & (k units) Table 186. SAMEA BCG Tuberculosis (TB) Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 187. SAMEA BCG Tuberculosis (TB) Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 188. SAMEA BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA BCG Tuberculosis (TB) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2026) & (k units) Table 191. SAMEA BCG Tuberculosis (TB) Vaccine Sales by Application (2027-2032) & (k units) Table 192. SAMEA BCG Tuberculosis (TB) Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 193. SAMEA BCG Tuberculosis (TB) Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 194. SAMEA BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA BCG Tuberculosis (TB) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 198. SAMEA BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2026) & (k units) Table 199. SAMEA BCG Tuberculosis (TB) Vaccine Sales by Country (2027-2032) & (k units) Table 200. SAMEA BCG Tuberculosis (TB) Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 201. SAMEA BCG Tuberculosis (TB) Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 202. Brazil BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 203. Argentina BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 204. Chile BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 205. Colombia BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 206. Peru BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 208. Israel BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 209. UAE BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 210. Turkey BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Iran BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Egypt BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. BCG Tuberculosis (TB) Vaccine Distributors List Table 216. BCG Tuberculosis (TB) Vaccine Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. BCG Tuberculosis (TB) Vaccine Image Figure 2. Global BCG Tuberculosis (TB) Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global BCG Tuberculosis (TB) Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immune BCG Image Figure 5. Therapy BCG Image Figure 6. Global BCG Tuberculosis (TB) Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global BCG Tuberculosis (TB) Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global BCG Tuberculosis (TB) Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global BCG Tuberculosis (TB) Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global BCG Tuberculosis (TB) Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global BCG Tuberculosis (TB) Vaccine Sales (2021-2032) & (k units) Figure 16. Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico BCG Tuberculosis (TB) Vaccine Sales YoY (2021-2032) & (k units) Figure 19. Europe BCG Tuberculosis (TB) Vaccine Sales YoY (2021-2032) & (k units) Figure 20. China BCG Tuberculosis (TB) Vaccine Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) BCG Tuberculosis (TB) Vaccine Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales YoY (2021-2032) & (k units) Figure 23. Global BCG Tuberculosis (TB) Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global BCG Tuberculosis (TB) Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America BCG Tuberculosis (TB) Vaccine Revenue Share by Type (2021-2032) Figure 39. North America BCG Tuberculosis (TB) Vaccine Sales Share by Type (2021-2032) Figure 40. North America BCG Tuberculosis (TB) Vaccine Revenue Share by Application (2021-2032) Figure 41. North America BCG Tuberculosis (TB) Vaccine Sales Share by Application (2021-2032) Figure 42. North America BCG Tuberculosis (TB) Vaccine Revenue Share by Country (2021-2032) Figure 43. North America BCG Tuberculosis (TB) Vaccine Sales Share by Country (2021-2032) Figure 44. Europe BCG Tuberculosis (TB) Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe BCG Tuberculosis (TB) Vaccine Sales Share by Type (2021-2032) Figure 46. Europe BCG Tuberculosis (TB) Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe BCG Tuberculosis (TB) Vaccine Sales Share by Application (2021-2032) Figure 48. Europe BCG Tuberculosis (TB) Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe BCG Tuberculosis (TB) Vaccine Sales Share by Country (2021-2032) Figure 50. China BCG Tuberculosis (TB) Vaccine Revenue Share by Type (2021-2032) Figure 51. China BCG Tuberculosis (TB) Vaccine Sales Share by Type (2021-2032) Figure 52. China BCG Tuberculosis (TB) Vaccine Revenue Share by Application (2021-2032) Figure 53. China BCG Tuberculosis (TB) Vaccine Sales Share by Application (2021-2032) Figure 54. Asia BCG Tuberculosis (TB) Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia BCG Tuberculosis (TB) Vaccine Sales Share by Type (2021-2032) Figure 56. Asia BCG Tuberculosis (TB) Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia BCG Tuberculosis (TB) Vaccine Sales Share by Application (2021-2032) Figure 58. Asia BCG Tuberculosis (TB) Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia BCG Tuberculosis (TB) Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA BCG Tuberculosis (TB) Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA BCG Tuberculosis (TB) Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA BCG Tuberculosis (TB) Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA BCG Tuberculosis (TB) Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA BCG Tuberculosis (TB) Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA BCG Tuberculosis (TB) Vaccine Sales Share by Country (2021-2032) Figure 66. BCG Tuberculosis (TB) Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. BCG Tuberculosis (TB) Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Immune BCG
  • Therapy BCG
Applications
  • Hospital
  • Clinic
Companies covered
  • China National Biotec
  • Sanofi Pasteur
  • Merck
  • Serum Institute of India
  • Japan BCG Lab
  • Intervax
  • GSBPL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 BCG Tuberculosis (TB) Vaccine Market by Type
  3. 1.2.1 Global BCG Tuberculosis (TB) Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immune BCG
  5. 1.2.3 Therapy BCG
  6. 1.3 BCG Tuberculosis (TB) Vaccine Market by Application
  7. 1.3.1 Global BCG Tuberculosis (TB) Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 BCG Tuberculosis (TB) Vaccine Market Dynamics
  1. 2.1 BCG Tuberculosis (TB) Vaccine Industry Trends
  2. 2.2 BCG Tuberculosis (TB) Vaccine Industry Drivers
  3. 2.3 BCG Tuberculosis (TB) Vaccine Industry Opportunities and Challenges
  4. 2.4 BCG Tuberculosis (TB) Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global BCG Tuberculosis (TB) Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Region
  3. 3.2.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global BCG Tuberculosis (TB) Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global BCG Tuberculosis (TB) Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global BCG Tuberculosis (TB) Vaccine Sales by Region
  9. 3.4.1 Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global BCG Tuberculosis (TB) Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global BCG Tuberculosis (TB) Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturers
  2. 4.1.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global BCG Tuberculosis (TB) Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global BCG Tuberculosis (TB) Vaccine Sales by Manufacturers
  6. 4.2.1 Global BCG Tuberculosis (TB) Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global BCG Tuberculosis (TB) Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global BCG Tuberculosis (TB) Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global BCG Tuberculosis (TB) Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global BCG Tuberculosis (TB) Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global BCG Tuberculosis (TB) Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global BCG Tuberculosis (TB) Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global BCG Tuberculosis (TB) Vaccine Market CR5 and HHI
  16. 4.8.2 2025 BCG Tuberculosis (TB) Vaccine Tier 1, Tier 2, and Tier 3
5 BCG Tuberculosis (TB) Vaccine Market by Type
  1. 5.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Type
  2. 5.1.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global BCG Tuberculosis (TB) Vaccine Sales by Type
  6. 5.2.1 Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global BCG Tuberculosis (TB) Vaccine Price by Type
6 BCG Tuberculosis (TB) Vaccine Market by Application
  1. 6.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Application
  2. 6.1.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global BCG Tuberculosis (TB) Vaccine Sales by Application
  6. 6.2.1 Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global BCG Tuberculosis (TB) Vaccine Price by Application
7 Company Profiles
  1. 7.1 China National Biotec
  2. 7.1.1 China National Biotec Company Information
  3. 7.1.2 China National Biotec Business Overview
  4. 7.1.3 China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 China National Biotec BCG Tuberculosis (TB) Vaccine Product Portfolio
  6. 7.1.5 China National Biotec Recent Developments
  7. 7.2 Sanofi Pasteur
  8. 7.2.1 Sanofi Pasteur Company Information
  9. 7.2.2 Sanofi Pasteur Business Overview
  10. 7.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Portfolio
  12. 7.2.5 Sanofi Pasteur Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck BCG Tuberculosis (TB) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck BCG Tuberculosis (TB) Vaccine Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Serum Institute of India
  20. 7.4.1 Serum Institute of India Company Information
  21. 7.4.2 Serum Institute of India Business Overview
  22. 7.4.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Portfolio
  24. 7.4.5 Serum Institute of India Recent Developments
  25. 7.5 Japan BCG Lab
  26. 7.5.1 Japan BCG Lab Company Information
  27. 7.5.2 Japan BCG Lab Business Overview
  28. 7.5.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Portfolio
  30. 7.5.5 Japan BCG Lab Recent Developments
  31. 7.6 Intervax
  32. 7.6.1 Intervax Company Information
  33. 7.6.2 Intervax Business Overview
  34. 7.6.3 Intervax BCG Tuberculosis (TB) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Intervax BCG Tuberculosis (TB) Vaccine Product Portfolio
  36. 7.6.5 Intervax Recent Developments
  37. 7.7 GSBPL
  38. 7.7.1 GSBPL Company Information
  39. 7.7.2 GSBPL Business Overview
  40. 7.7.3 GSBPL BCG Tuberculosis (TB) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GSBPL BCG Tuberculosis (TB) Vaccine Product Portfolio
  42. 7.7.5 GSBPL Recent Developments
8 North America
  1. 8.1 North America BCG Tuberculosis (TB) Vaccine Market Size by Type
  2. 8.1.1 North America BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America BCG Tuberculosis (TB) Vaccine Price by Type (2021-2032)
  5. 8.2 North America BCG Tuberculosis (TB) Vaccine Market Size by Application
  6. 8.2.1 North America BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America BCG Tuberculosis (TB) Vaccine Price by Application (2021-2032)
  9. 8.3 North America BCG Tuberculosis (TB) Vaccine Market Size by Country
  10. 8.3.1 North America BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America BCG Tuberculosis (TB) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America BCG Tuberculosis (TB) Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe BCG Tuberculosis (TB) Vaccine Market Size by Type
  2. 9.1.1 Europe BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe BCG Tuberculosis (TB) Vaccine Price by Type (2021-2032)
  5. 9.2 Europe BCG Tuberculosis (TB) Vaccine Market Size by Application
  6. 9.2.1 Europe BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe BCG Tuberculosis (TB) Vaccine Price by Application (2021-2032)
  9. 9.3 Europe BCG Tuberculosis (TB) Vaccine Market Size by Country
  10. 9.3.1 Europe BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe BCG Tuberculosis (TB) Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China BCG Tuberculosis (TB) Vaccine Market Size by Type
  2. 10.1.1 China BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China BCG Tuberculosis (TB) Vaccine Price by Type (2021-2032)
  5. 10.2 China BCG Tuberculosis (TB) Vaccine Market Size by Application
  6. 10.2.1 China BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China BCG Tuberculosis (TB) Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia BCG Tuberculosis (TB) Vaccine Market Size by Type
  2. 11.1.1 Asia BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia BCG Tuberculosis (TB) Vaccine Price by Type (2021-2032)
  5. 11.2 Asia BCG Tuberculosis (TB) Vaccine Market Size by Application
  6. 11.2.1 Asia BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia BCG Tuberculosis (TB) Vaccine Price by Application (2021-2032)
  9. 11.3 Asia BCG Tuberculosis (TB) Vaccine Market Size by Country
  10. 11.3.1 Asia BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia BCG Tuberculosis (TB) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia BCG Tuberculosis (TB) Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA BCG Tuberculosis (TB) Vaccine Market Size by Type
  2. 12.1.1 SAMEA BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA BCG Tuberculosis (TB) Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA BCG Tuberculosis (TB) Vaccine Market Size by Application
  6. 12.2.1 SAMEA BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA BCG Tuberculosis (TB) Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA BCG Tuberculosis (TB) Vaccine Market Size by Country
  10. 12.3.1 SAMEA BCG Tuberculosis (TB) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA BCG Tuberculosis (TB) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA BCG Tuberculosis (TB) Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 BCG Tuberculosis (TB) Vaccine Value Chain Analysis
  2. 13.1.1 BCG Tuberculosis (TB) Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 BCG Tuberculosis (TB) Vaccine Production Mode & Process
  6. 13.2 BCG Tuberculosis (TB) Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 BCG Tuberculosis (TB) Vaccine Distributors
  9. 13.2.3 BCG Tuberculosis (TB) Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst